Overview
This study aims to characterize Swiss HIV Cohort Study participants initiating the CAB+RPV LA regimen, assess adherence to Swiss label indications, and describe treatment outcomes in this large, multicentre, heterogeneous, high-income setting. Moreover, the study aims to assess virological, immunological, demographic, clinical, and behavioural factors associated with viral failure under CAB+RPV LA regimen.
Eligibility
Inclusion Criteria:
- Participant in the SHCS
- All SHCS participants initiating the CAB+RPV LA regimen
- All SHCS participants on SOC oral regimen
Exclusion Criteria:
- Not participating in the SHCS